Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Advanced Enzyme Technologies's
Operating Income
for the
three
months ended in Mar. 2026 was ₹530 Mil. Advanced Enzyme Technologies's Interest Expense for the
three
months ended in Mar. 2026 was ₹-6 Mil.
Advanced Enzyme Technologies's interest coverage for the quarter that ended in Mar. 2026 was 92.56.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Advanced Enzyme Technologies Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Advanced Enzyme Technologies's Interest Coverage or its related term are showing as below:
NSE:ADVENZYMES'
s Interest Coverage Range Over the Past 10 Years
Min: 31.76 Med: 58.08 Max: 130.21
Current: 71.93
NSE:ADVENZYMES's Interest Coverage is ranked better than 81.99% of 1244
companies
in the Chemicals industry
Industry Median: 10.355
vs NSE:ADVENZYMES: 71.93
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Advanced Enzyme Technologies Interest Coverage Related Terms
Advanced Enzyme Technologies Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:ADVENZYMES vs LIN, SHW, ECL: Interest Coverage Comparison
For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Enzyme Technologies Interest Coverage vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Advanced Enzyme Technologies's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a Interest Coverage of 92.56 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Advanced Enzyme Technologies and its competitors. This is 59% above median its historical median of 58.08. Over the past decade, Advanced Enzyme Technologies' Interest Coverage has ranged from 31.76 to 130.21. According to the industry distribution chart, Advanced Enzyme Technologies ranks #224 out of 1244 companies in the Chemicals industry, placing it in the top 18%.
Is Advanced Enzyme Technologies' Interest Coverage too high?
Advanced Enzyme Technologies' current Interest Coverage of 92.56 is 59% above median its 10-year median of 58.08. Over the past 10 years, this metric has ranged from a low of 31.76 to a high of 130.21. The Chemicals industry median Interest Coverage is 10.36. Advanced Enzyme Technologies' value of 92.56 is 793.9% above this industry median. Based on the distribution chart, Advanced Enzyme Technologies ranks #224 out of 1244 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Advanced Enzyme Technologies has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' Interest Coverage compare to LIN and SHW?
According to the Chemicals industry distribution chart, Advanced Enzyme Technologies ranks #224 out of 1244 companies for Interest Coverage. This places Advanced Enzyme Technologies in the top 18% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 10.36. Advanced Enzyme Technologies' value of 92.56 is 793.9% above this benchmark. Historically, Advanced Enzyme Technologies' own Interest Coverage has ranged from 31.76 to 130.21 over the past decade. While the company's 10-year median is 58.08 vs. the industry median of 10.36, Advanced Enzyme Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Chemicals company?
The median Interest Coverage among Chemicals companies is 10.36, based on 1,244 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Enzyme Technologies's current Interest Coverage of 92.56 is 793.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Advanced Enzyme Technologies and its competitors. For the Chemicals industry, the median Interest Coverage is 10.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Enzyme Technologies's current Interest Coverage is 92.56, which is 59% above median its own 10-year median of 58.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.89, compared to a current price of ₹324.35 — trading 22.9% below its estimated fair value. The current Interest Coverage is 92.56, which is 59% above median its 10-year median of 58.08 and 793.9% above the Chemicals industry median of 10.36. Advanced Enzyme Technologies' overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current Interest Coverage is 92.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued.
The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89.
GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.
Key valuation signals for NSE:ADVENZYMES:
Interest Coverage: 92.56 (59% above median its 10-year median of 58.08)
GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
Industry Position: 793.9% above the Chemicals median (#224 of 1244)
No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score
Get the complete analysis for NSE:ADVENZYMES
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ADVENZYMES has been successfully added to your 
